Carrillo Juan J, Pediani John, Milligan Graeme
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K.
J Biol Chem. 2003 Oct 24;278(43):42578-87. doi: 10.1074/jbc.M306165200. Epub 2003 Aug 14.
The histamine H1 receptor and the alpha1b-adrenoreceptor are G protein-coupled receptors that elevate intracellular [Ca2+] via activation of Gq/G11. Assessed by co-immunoprecipitation and time-resolved fluorescence resonance energy transfer they both exist as homo-dimers. The addition of the G protein G11alpha to the C terminus of these receptors did not prevent dimerization. Agonists produced a large stimulation of guanosine 5'-3-O-([35S]thio)triphosphate ([35S]GTPgammaS) binding to receptor-G protein fusions containing wild type forms of both polypeptides. For both receptors this was abolished by incorporation of G208AG11alpha into the fusions. Mutation of a highly conserved leucine in intracellular loop 2 of each receptor also eliminated agonist function but not binding. Co-expression of the two non-functional but complementary fusion constructs reconstituted agonist-mediated binding of [35S]GTPgammaS in membranes of HEK293 cells and elevation of [Ca2+]i in mouse embryo fibroblasts lacking both Gq and G11. Co-expression of the histamine H1 receptor- and the alpha1b-adrenoreceptor-G11alpha fusions allowed detection of functional hetero-dimeric complexes, whereas co-expression of histamine H1 receptor-G11alpha with increasing amounts of L151Dalpha1b-adrenoreceptor resulted in decreasing levels of histamine-stimulated [35S]GTPgammaS binding. Co-expression of the alpha1b-adrenoreceptor with a fusion protein incorporating the N-terminal domain and transmembrane helix 1 of the alpha1b-adrenoreceptor and G11alpha did not result in agonist activation of the G protein but did indicate a role for transmembrane helix 1 in dimerization. These data demonstrate that dimers of these class A receptors function via trans-activation of associated G proteins.
组胺H1受体和α1b -肾上腺素受体是G蛋白偶联受体,通过激活Gq / G11升高细胞内[Ca2 +]。通过共免疫沉淀和时间分辨荧光共振能量转移评估,它们均以同二聚体形式存在。将G蛋白G11α添加到这些受体的C末端并未阻止二聚化。激动剂对鸟苷5'-3 - O -([35S]硫代)三磷酸([35S] GTPγS)与包含两种多肽野生型形式的受体 - G蛋白融合体的结合产生了强烈刺激。对于这两种受体,通过将G208A G11α掺入融合体中,这种刺激被消除。每个受体细胞内环2中高度保守的亮氨酸突变也消除了激动剂功能,但未消除结合。两种无功能但互补的融合构建体的共表达在HEK293细胞膜中重建了激动剂介导的[35S] GTPγS结合,并在缺乏Gq和G11的小鼠胚胎成纤维细胞中升高了[Ca2 +]i。组胺H1受体和α1b -肾上腺素受体 - G11α融合体的共表达允许检测功能性异二聚体复合物,而组胺H1受体 - G11α与越来越多的L151Dα1b -肾上腺素受体的共表达导致组胺刺激的[35S] GTPγS结合水平降低。α1b -肾上腺素受体与包含α1b -肾上腺素受体的N末端结构域和跨膜螺旋1以及G11α的融合蛋白的共表达并未导致G蛋白的激动剂激活,但确实表明跨膜螺旋1在二聚化中起作用。这些数据表明,这些A类受体的二聚体通过相关G蛋白的反式激活发挥作用。